• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
20S-Ginsenoside Rg3

20S-Ginsenoside Rg3

Product ID G3552
Cas No. 14197-60-5
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $171.30 In stock
10 mg $296.00 In stock
25 mg $591.70 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Ginsenoside Rg3 is a triterpene saponin found in Panax that exhibits neuromodulatory, cognition enhancing, anti-inflammatory, antioxidative, anti-angiogenic, and anticancer activities. Ginsenoside Rg3 activates KCNQ1/Kv7.1 K+ channels and the γ2 subunit of GABA-A receptors and inhibits the α10 subunit of nicotinic acetylcholine receptors (nAChRs). In animal models, ginsenoside Rg3 decreases expression of TNF-α, IL-1β, and COX-2 in the hippocampus, improving learning and memory deficits. In vitro, ginsenoside Rg3 prevents LPS-induced upregulation of TNF-α, IL-1β, and IL-6 levels and decreases activation of microglia. In other animal models, this compound decreases oxidative stress by increasing activity of catalase, superoxide dismutase (SOD), and lysozyme and decreasing levels of NO and malondialdehyde. Ginsenoside Rg3 also exhibits anti-angiogenic benefit, inhibiting VEGF/p38/ERK signaling to inhibit tubular formation and migration of endothelial progenitor cells. In osteosarcoma cells, this compound increased DNA damage by inducing strand breaks into double-stranded DNA.

Product Info

Cas No.

14197-60-5

Purity

≥98%

Formula

C42H72O13

Formula Wt.

785.01

IUPAC Name

2-[4,5-dihydroxy-2-[[12-hydroxy-17-(2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Synonym

Ginsenoside Rg3

Appearance

White to off white powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

G3552 MSDS PDF

Info Sheet

G3552 Info Sheet PDF

References

Zhang YH, Li HD, Li B, et al. Ginsenoside Rg3 induces DNA damage in human osteosarcoma cells and reduces MNNG-induced DNA damage and apoptosis in normal human cells. Oncol Rep. 2014 Feb;31(2):919-25. PMID: 24337872.

Lee B, Sur B, Park J, et al. Ginsenoside rg3 alleviates lipopolysaccharide-induced learning and memory impairments by anti-inflammatory activity in rats. Biomol Ther (Seoul). 2013 Sep 30;21(5):381-90. PMID: 24244826.

Lee BH, Choi SH, Hwang SH, et al. Effects of ginsenoside Rg3 on α9α10 nicotinic acetylcholine receptor-mediated ion currents. Biol Pharm Bull. 2013;36(5):812-8. PMID: 23649337.

Lee BH, Kim HJ, Chung L, et al. Ginsenoside Rg₃ regulates GABAA receptor channel activity: involvement of interaction with the γ₂ subunit. Eur J Pharmacol. 2013 Apr 5;705(1-3):119-25. PMID: 23499684.

Park SM, Choi MS, Sohn NW, et al. Ginsenoside Rg3 attenuates microglia activation following systemic lipopolysaccharide treatment in mice. Biol Pharm Bull. 2012;35(9):1546-52. PMID: 22975507.

Wei X, Su F, Su X, et al. Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice. Fitoterapia. 2012 Jun;83(4):636-42. PMID: 22310172.

Kim JW, Jung SY, Kwon YH, et al. Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells. Cancer Biol Ther. 2012 May;13(7):504-15. PMID: 22406998.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • I7258

    Isoflurane

    Ca2+ ATPase and ATP-sensitive K+ channel activa...

    ≥98%
  • P4008

    PKC412

    Staurosporine derivative; PKC and FLT3 inhibito...

    ≥98%
  • J3205

    Z-JIB-04

    Jumonji histone demethylase inhibitor.

    ≥98%
  • A6970

    Artemether

    Sesquiterpene lactone derived from Artemesia.

    ≥98%
  • A225822

    Afuresertib

    Inhibitor of Akt.

    ≥98%
  • A7085

    Arvanil

    CB1 agonist, TRPV1 agonist.

    ≥98%
  • F4857

    FMRF Amide

    Cardiostimulatory neuropeptide; delayed rectifi...

    ≥95%
  • W0274

    S-(−)-Warfarin Sodium >99%ee

    Coumarin, more potent isomer; VKORC1 inhibitor....

    ≥99%
  • T3098

    Thymosin β-4 Acetate

    Endogenous peptide; actin polymerization inhibi...

    ≥95%
  • C0250

    Calcitonin Gene Related Peptide II, human

    Calcitonin-family peptide, involved in vasodila...

    ≥95%
  • E6997

    Erythropoietin, Human Recombinant

    Endogenous glycoprotein hormone involved in red...

    ≥97%
  • T3203

    Tianeptine Sodium Hydrate

    μOR and δOR agonist, D2/D3 DA potentiator.

    ≥98%
  • P4132

    PKI-402

    p110α PI3K and mTOR inhibitor.

    ≥98%
  • B4974

    BMS-777607

    MET and Ron inhibitor.

    ≥99%
  • I538583

    Inosine

    Adenosine analog

    ≥98%
  • A7658

    Atorvastatin Calcium Trihydrate

    Statin; HMG-CoA reductase inhibitor.

    ≥98%
  • A5234

    Amisulpride

    5-HT7 and D2/3 antagonist.

    ≥98%
  • C1878

    Cetrimide

    Mixture of quaternary ammonium salts, cationic ...

    ≥98%
  • O486181

    Omeprazole Related Compound B

    Impurity of omeprazole

    ≥99%
  • H1657

    Heparin-binding Peptide

    Peptide, binds heparin.

    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only